Inventor · disambiguated record
Melanie Janelle Bevill
Also filed as: BEVILL MELANIE · BEVILL MELANIE J · BEVILL MELANIE JANELLE
21 granted patents·6 pending applications·47 citations·filing 2011–2024
93Inventor score
Top patents by PatentIndex Score
27 records- 0197US11725018B2CrystalsAEROMICS INC·Filed 2021·Granted Aug 15, 2023·4 cites·20 claims
- 0295US12091431B2CrystalsAEROMICS INC·Filed 2023·Granted Sep 17, 2024·2 cites·18 claims
- 0394US11117909B2CrystalsAEROMICS INC·Filed 2017·Granted Sep 14, 2021·6 cites·30 claims
- 0485US8754098B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2012·Granted Jun 17, 2014·5 cites·22 claims
- 0585US2025206765A1CrystalsAEROMICS INC·Filed 2024·Application pending·0 cites
- 0684US9314459B2Polymorphs of cocrystals of p-Coumaric acid:nicotinamideAMRI SSCI LLC·Filed 2015·Granted Apr 19, 2016·3 cites·8 claims
- 0784US9120766B2Methods of making cocrystalsAPTUIT WEST LAFAYETTE LLC·Filed 2012·Granted Sep 1, 2015·7 cites·15 claims
- 0883US10717755B2Co-crystal forms of a novobiocin analog and prolineREATA PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·43 claims
- 0983US9181274B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2012·Granted Nov 10, 2015·4 cites·7 claims
- 1083US8513275B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2011·Granted Aug 20, 2013·8 cites·6 claims
- 1182US8815888B2Forms of rifaximin and uses thereofWU YIDUO·Filed 2013·Granted Aug 26, 2014·6 cites·20 claims
- 1275US2024043465A1Co-crystal forms of a novobiocin analog and prolineREATA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1372US12017995B2Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2019·Granted Jun 25, 2024·0 cites·2 claims
- 1471US9585892B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 7, 2017·1 cites·20 claims
- 1568US11401294B2Co-crystal forms of a novobiocin analog and prolineREATA PHARMACEUTICALS INC·Filed 2020·Granted Aug 2, 2022·0 cites·19 claims
- 1668US9359357B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2014·Granted Jun 7, 2016·0 cites·17 claims
- 1766US2024300897A1Crystalline forms and salt forms of a kinase inhibitorEXELIXIS INC·Filed 2024·Application pending·0 cites
- 1865US9512166B2Cocrystals of progesteroneAMRI SSCI LLC·Filed 2013·Granted Dec 6, 2016·0 cites·9 claims
- 1963US2025215002A1Solid forms of tyk2 inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2062US9700545B2Forms of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2016·Granted Jul 11, 2017·0 cites·5 claims
- 2160US9982007B2Cocrystals of progesteroneAMRI SSCI LLC·Filed 2016·Granted May 29, 2018·0 cites·20 claims
- 2258US10004726B2Polymorphs of cocrystals of P-coumaric acid:nicotinamideAMRI SSCI LLC·Filed 2016·Granted Jun 26, 2018·0 cites·12 claims
- 2356US2016097142A1Methods of making cocrystalsAMRI SSCI LLC·Filed 2015·Application pending·0 cites
- 2454US12351588B2Salt forms and solvates of Mcl-1 antagonistsAMGEN INC·Filed 2023·Granted Jul 8, 2025·0 cites·17 claims
- 2554US10098859B2Cocrystals of p-coumaric acidAMRI SSCI LLC·Filed 2013·Granted Oct 16, 2018·0 cites·11 claims
- 2654US2023052703A1Salt Forms of a Kinase InhibitorEXELIXIS INC·Filed 2019·Application pending·0 cites
- 2749US12459890B2Salt and crystal form of compound having agonistic activity to S1P5 receptorONO PHARMACEUTICAL CO·Filed 2020·Granted Nov 4, 2025·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →